FDA expands data mining contract
Executive Summary
FDA is renewing a contract to allow the Office of Drug Safety to access San Diego-based Premier's database for inpatient drug utilization information. The agency is also awarding a contract that would allow the Division of Pediatric Drug Development to use Premier's pediatric inpatient data. The utilization data provides context for adverse event reports, modeling of drug risk based on usage patterns and calculating reporting rates for inpatient drug use, Premier said. FDA first contracted for access to Premier's inpatient data in 2001; the agency previously used the Child Health Corporation of America database for pediatric information (1"The Pink Sheet" Oct. 22, 2001, p. 9)...
You may also be interested in...
Off-Label Pediatric Drug Use To Be Tracked Through FDA Database Contracts
Off-label drug use in pediatric patients will be tracked under FDA contracts for longitudinal prescription data.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.